Comparison

P2X7-IN-2 (TFA) European Partner

Item no. HY-18725A-10mg
Manufacturer MedChem Express
Amount 10 mg
Quantity options 100 mg 10 mg 25 mg 50 mg 5 mg
Category
Type Reagents
Specific against other
Purity 99.93
Formula C24H22F7N3O4
Citations [1]Kelly, Michael G, et al. Preparation of isoquinolonecarboxamides as P2X7 purinoceptor modulators and uses thereof. WO2008112205 A1. 2008.
Smiles O=C(NC1=C(C)C=CC2=C1C=CN([C@H](C)CN)C2=O)CC3=CC=C(C(F)(F)F)C(F)=C3.O=C(O)C(F)(F)F
ECLASS 10.1 42051003
ECLASS 11.0 42051003
UNSPSC 12000000
Available
Product Description
P2X7-IN-2 TFA (compound 58) is a P2X7 receptor inhibitor. P2X7-IN-2 TFA inhibits IL-Iβ release with an IC50 value of 0.01 nM. P2X7-IN-2 TFA can be used for the research of autoimmunity, inflammation and cardiovascular disease[1].
StorageTemperature
4°C (Powder, protect from light, stored under nitrogen)
Shipping
Room Temperature
Manufacturers Applications
COVID-19-immunoregulation
MolecularWeight
549.44
Clinical Information
No Development Reported
Manufacturers Research Area
Inflammation/Immunology; Cardiovascular Disease
Solubility
DMSO : 100 mg/mL (ultrasonic; warming; heat to 60°C)
Target
Interleukin Related; P2X Receptor
Manufacturers Target
Interleukin Related; P2X Receptor
Manufacturers Pathway
Immunology/Inflammation; Membrane Transporter/Ion Channel
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close